Page last updated: 2024-12-08

19-hydroxydeoxycorticosterone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 19-Hydroxydeoxycorticosterone (19-OH-DOC)

19-Hydroxydeoxycorticosterone (19-OH-DOC) is a steroid hormone that is a precursor to aldosterone, a key hormone in regulating blood pressure and electrolyte balance.

**Here's a breakdown:**

* **Structure:** 19-OH-DOC is a derivative of deoxycorticosterone (DOC), with an additional hydroxyl group at the 19th carbon position.
* **Synthesis:** 19-OH-DOC is synthesized in the adrenal glands, specifically in the zona glomerulosa, the outermost layer of the adrenal cortex.
* **Role:** 19-OH-DOC is an intermediate in the synthesis of aldosterone. It is converted to aldosterone by the enzyme aldosterone synthase.
* **Clinical Significance:** 19-OH-DOC itself has minimal biological activity. However, its role as a precursor to aldosterone makes it important for studying aldosterone synthesis and related conditions.

**Importance in Research:**

19-OH-DOC is important for research due to its involvement in various physiological and pathological processes:

* **Aldosterone Synthesis:** Researchers study 19-OH-DOC to understand the regulation of aldosterone production. This includes investigating the activity of aldosterone synthase and the factors that influence its activity.
* **Hypertension and Sodium Retention:** 19-OH-DOC levels can be elevated in conditions associated with high blood pressure and sodium retention, like Conn's syndrome.
* **Drug Development:** 19-OH-DOC serves as a target for developing drugs that modulate aldosterone synthesis. This could be helpful in managing hypertension and other cardiovascular diseases.
* **Endocrine Disorders:** 19-OH-DOC levels can be measured to diagnose and monitor various endocrine disorders, such as adrenal insufficiency and adrenal hyperplasia.
* **Steroid Hormone Metabolism:** Research on 19-OH-DOC provides insights into the complex pathways of steroid hormone metabolism and the factors that influence their production and breakdown.

**In conclusion:**

19-OH-DOC is a crucial intermediate in the synthesis of aldosterone, a hormone vital for maintaining blood pressure and electrolyte balance. Its importance in research lies in its role in understanding aldosterone synthesis, developing new therapies for cardiovascular disease, and diagnosing and monitoring various endocrine disorders.

19-hydroxydeoxycorticosterone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID164961
CHEBI ID195167
SCHEMBL ID8206917
MeSH IDM0090184

Synonyms (11)

Synonym
2394-23-2
pregn-4-ene-3,20-dione, 19,21-dihydroxy-
19-hydroxydeoxycorticosterone
19,21-dihydroxyprogesterone
19-oh-doc
CHEBI:195167
SCHEMBL8206917
LFISWQXWWGJHBL-ZOCXKQACSA-N
19,21-dihydroxypregn-4-ene-3,20-dione #
(2s,14s,15s)-14-(2-hydroxyacetyl)-2-(hydroxymethyl)-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one
DTXSID20946759
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (4)

ClassDescription
19-hydroxydeoxycorticosterone
20-oxo steroidAn oxo steroid carrying an oxo group at position 20.
21-hydroxy steroid
3-oxo-Delta(4) steroidA 3-oxo steroid conjugated to a C=C double bond at the alpha,beta position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.25 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]